Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-05-11 Sale | 2026-05-12 8:30 pm | GENELUX Corp | GNLX | Yu Yong Chief Scientific Officer | 605 | $2.9726 | $1,798 | 149,706 (Direct) | View |
| 2026-05-11 Sale | 2026-05-12 8:30 pm | GENELUX Corp | GNLX | Cappello Joseph Chief Technical Officer | 605 | $2.9742 | $1,799 | 154,549 (Direct) | View |
| 2026-05-11 Sale | 2026-05-12 8:30 pm | GENELUX Corp | GNLX | Zindrick Thomas President and CEO | 2,798 | $2.9398 | $8,226 | 532,051 (Direct) | View |
| 2026-05-11 Sale | 2026-05-12 8:30 pm | GENELUX Corp | GNLX | Smalling Ralph Head of Regulatory | 270 | $2.9796 | $804 | 67,803 (Direct) | View |
| 2026-03-24 Sale | 2026-03-26 5:00 pm | GENELUX Corp | GNLX | Smalling Ralph Head of Regulatory | 585 | $2.4569 | $1,437 | 68,073 (Direct) | View |
| 2026-03-24 Sale | 2026-03-26 5:00 pm | GENELUX Corp | GNLX | Cappello Joseph Chief Technical Officer | 906 | $2.42 | $2,193 | 155,154 (Direct) | View |
| 2026-03-24 Sale | 2026-03-26 5:00 pm | GENELUX Corp | GNLX | Yu Yong SVP, Clinical Development | 906 | $2.42 | $2,193 | 144,938 (Direct) | View |
| 2026-03-24 Sale | 2026-03-26 5:00 pm | GENELUX Corp | GNLX | Zindrick Thomas President and CEO | 3,582 | $2.42 | $8,668 | 534,849 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 8:05 pm | GENELUX Corp | GNLX | Thomas John Director | 10,000 | $2.8957 | $28,957 | 482,784 (Direct) | View |
| 2025-08-21 Sale | 2025-12-11 8:50 pm | GENELUX Corp | GNLX | Yu Yong SVP, Clinical Development | 4,192 | $3.8244 | $16,032 | 145,844 (Direct) | View |
| 2025-08-21 Sale | 2025-12-11 8:50 pm | GENELUX Corp | GNLX | Zindrick Thomas President and CEO | 17,182 | $3.8628 | $66,370 | 538,431 (Direct) | View |
| 2025-08-21 Sale | 2025-12-11 8:49 pm | GENELUX Corp | GNLX | Cappello Joseph Chief Technical Officer | 3,706 | $3.8751 | $14,361 | 156,060 (Direct) | View |
| 2025-08-21 Sale | 2025-12-09 8:00 pm | GENELUX Corp | GNLX | Smalling Ralph Head of Regulatory | 2,332 | $3.748 | $8,740 | 68,658 (Direct) | View |
| 2025-12-01 Sale | 2025-12-02 7:00 pm | GENELUX Corp | GNLX | Thomas John Director | 10,000 | $5.0008 | $50,008 | 492,784 (Direct) | View |
| 2025-05-12 Sale | 2025-05-13 5:05 pm | GENELUX Corp | GNLX | Ryder Sean General Counsel | 4,475 | $2.92 | $13,067 | 47,621 (Direct) | View |
| 2025-05-12 Sale | 2025-05-13 5:05 pm | GENELUX Corp | GNLX | Zindrick Thomas President and CEO | 10,764 | $2.92 | $31,431 | 191,447 (Direct) | View |
| 2025-05-12 Sale | 2025-05-13 5:05 pm | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 5,579 | $2.92 | $16,291 | 47,640 (Direct) | View |
| 2025-05-12 Sale | 2025-05-13 5:05 pm | GENELUX Corp | GNLX | Cappello Joseph VP, Pharmaceutical Development | 4,737 | $2.92 | $13,832 | 52,266 (Direct) | View |
| 2025-05-12 Sale | 2025-05-13 5:05 pm | GENELUX Corp | GNLX | Smalling Ralph Head of Regulatory | 1,259 | $2.92 | $3,676 | 34,760 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-02 Option Award | 2026-01-07 5:32 pm | N/A 2036-01-01 | GENELUX Corp | GNLX | Litten Jason Chief Medical Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2025-09-01 Option Award | 2025-09-03 4:15 pm | N/A 2027-09-18 | GENELUX Corp | GNLX | Zindrick Thomas President and CEO | 1,355,940 | $0 | 1,355,940 (Direct) | View |
| 2025-09-01 Option Award | 2025-09-03 4:15 pm | N/A 2029-09-20 | GENELUX Corp | GNLX | Yu Yong SVP, Clinical Development | 272,652 | $0 | 272,652 (Direct) | View |
| 2025-09-01 Option Award | 2025-09-03 4:15 pm | N/A 2030-09-23 | GENELUX Corp | GNLX | Smalling Ralph Head of Regulatory | 18,333 | $0 | 79,323 (Direct) | View |
| 2025-09-01 Option Award | 2025-09-03 4:15 pm | N/A 2026-12-30 | GENELUX Corp | GNLX | Cappello Joseph Chief Technical Officer | 174,999 | $0 | 174,999 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Thomas John Director | 50,859 | $0 | 531,360 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Zindrick Thomas President and CEO | 840,000 | $0 | 1,032,961 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Smalling Ralph Head of Regulatory | 61,000 | $0 | 95,760 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Smither John W Director | 50,859 | $0 | 103,570 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Yu Yong SVP, Clinical Development | 236,000 | $0 | 284,556 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Mirabelli Mary Director | 50,859 | $0 | 101,860 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Tyree James L Director | 50,859 | $0 | 96,650 (Direct) | View |
| 2025-08-27 Option Award | 2025-08-29 4:30 pm | N/A 2035-08-26 | GENELUX Corp | GNLX | Cappello Joseph Chief Technical Officer | 250,000 | $0 | 302,266 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-02 4:16 pm | N/A 2035-06-30 | GENELUX Corp | GNLX | Groen Eric General Counsel & Secretary | 270,000 | $0 | 270,000 (Direct) | View |
| 2025-06-06 Gift | 2025-06-24 4:10 pm | N/A N/A | GENELUX Corp | GNLX | Thomas John Director | 25,000 | $0 | 480,501 (Direct) | View |
| 2025-03-14 Option Award | 2025-04-17 4:58 pm | N/A N/A | GENELUX Corp | GNLX | Smalling Ralph Head of Regulatory | 4,172 | $0 | 36,019 (Direct) | View |
| 2025-03-14 Option Award | 2025-04-17 4:57 pm | N/A N/A | GENELUX Corp | GNLX | Cappello Joseph VP, Pharmaceutical Development | 13,350 | $0 | 57,003 (Direct) | View |
| 2025-03-14 Option Award | 2025-04-17 4:56 pm | N/A N/A | GENELUX Corp | GNLX | Yu Yong VP, Clinical Trial Operations | 13,350 | $0 | 53,219 (Direct) | View |
| 2025-03-14 Option Award | 2025-04-17 4:55 pm | N/A N/A | GENELUX Corp | GNLX | Ryder Sean General Counsel | 10,708 | $0 | 52,096 (Direct) | View |